文件操作 - 1762818909.M336265P23273.mail.planetcloud-host.com,S=2301,W=2353:2,S
返回文件管理
返回主菜单
删除本文件
文件: /var/vmail/lareco.it/info/cur/1762818909.M336265P23273.mail.planetcloud-host.com,S=2301,W=2353:2,S
编辑文件内容
Return-Path: <export@microforge.it.com> Delivered-To: info@lareco.it Received: by mail.planetcloud-host.com (Postfix, from userid 1016) id 4152314593; Tue, 11 Nov 2025 00:55:09 +0100 (CET) X-Spam-Checker-Version: SpamAssassin 3.4.0 (2014-02-07) on mail.planetcloud-host.com X-Spam-Level: **** X-Spam-Status: No, score=4.8 required=6.0 tests=DKIM_ADSP_CUSTOM_MED, FREEMAIL_FROM,FREEMAIL_REPLYTO_END_DIGIT,NML_ADSP_CUSTOM_MED,ODD_FREEM_REPTO, RCVD_IN_DNSWL_BLOCKED,RCVD_IN_MSPIKE_BL,RCVD_IN_MSPIKE_L3,RCVD_IN_UCEPROTECT1, RCVD_IN_VALIDITY_RPBL_BLOCKED,RCVD_IN_VALIDITY_SAFE_BLOCKED,SPF_HELO_NONE, SPF_PASS,SUBJ_ALL_CAPS autolearn=disabled version=3.4.0 Received-SPF: Pass (sender SPF authorized) identity=mailfrom; client-ip=96.44.160.8; helo=mail.microforge.it.com; envelope-from=export@microforge.it.com; receiver=info@lareco.it Received: from mail.microforge.it.com (mail.microforge.it.com [96.44.160.8]) (using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits)) (No client certificate requested) by mail.planetcloud-host.com (Postfix) with ESMTPS id 4FB031450E for <info@lareco.it>; Tue, 11 Nov 2025 00:55:07 +0100 (CET) Received: from [::1] (helo=microforge.it.com) by mail.microforge.it.com with esmtpa (Exim 4.98.2) (envelope-from <export@microforge.it.com>) id 1vIbAq-0000000CsXG-01ag; Mon, 10 Nov 2025 18:19:48 -0500 MIME-Version: 1.0 Date: Mon, 10 Nov 2025 23:19:47 +0000 From: Allen James <aj3692467@gmail.com> To: undisclosed-recipients:; Subject: BUSINESS PROPOSAL Reply-To: aj3692467@gmail.com Mail-Reply-To: aj3692467@gmail.com Message-ID: <0045d7e14a45474b2e43ca3b590d5934@gmail.com> X-Sender: aj3692467@gmail.com Content-Type: text/plain; charset=US-ASCII; format=flowed Content-Transfer-Encoding: 7bit Sender: export@microforge.it.com Hello, I hope everything is good with you. We seek a trustworthy local representative, CEO, corporation, or individual to obtain raw materials for our project. We manufacture cancer treatments, antiviral vaccinations, and other life-saving medicines. Although not directly related to your field of expertise, this opportunity can be highly profitable for entrepreneurs. If you are interested, additional information can be provided. Warm regards. Allen James, (Pharmacure Laboratories Ltd., Research Assistant, UK)
修改文件时间
将文件时间修改为当前时间的前一年
删除文件